JUST IN
Schneider Electric India to set up 2nd unit in Telangana, invest Rs 300 cr
SC to hear pleas against TN, Maha's bull-taming sport Jallikattu on Nov 22
1 dead, 9 TMC supporters injured in accident while returning from rally
Modern bus stands to be built at six locations: Haryana transport minister
NCW seeks explanation from IAS officer over remark on sanitary napkins
Around 500 shop owners near Taj Mahal fear shutdown after SC order
Tamil Nadu police denies permission for state-wide RSS processions on Oct 2
Ankita Bhandari murder case: SIT questions revenue officers, employees
Malegaon blast case trial yet to examine 100 witnesses after 14 years
PM Modi holds roadshow in Surat; set to launch projects worth Rs 29,000 cr
You are here: Home » Current Affairs » Coronavirus » News
L&T delivers India's first launch hardware for human space programme
Business Standard

Coronavirus vaccine update: China Covid vaccine gives quick immune response

Moderna has joined Pfizer in approaching the Covid-19 vaccine finish line. Russia, India and Oxford vaccine are also making progress. Catch latest coronavirus vaccine updates and corona treatment here

Topics
Coronavirus Vaccine | Coronavirus | Coronavirus Tests

BS Web Team  |  New Delhi 

Coronavirus, vaccine, covid, drugs, clinical trials

Coronavirus vaccine update: In a year since the coronavirus pandemic hit the world, it has left over 1.3 million people dead and affected over 55 million across the globe. But some positive developments lately around a possible vaccine for the virus has raised some hopes. US-based Moderna has joined Pfizer in approaching the vaccine finish line, with the company saying its vaccine candidate is 94.5 per cent effective in preventing infection. For its part, Pfizer has announced last week that its vaccine candidate was over 90 per cent effective.

The two companies plan to apply for emergency-use authorisation later this month, and they could begin to immunise 20 million people as early as December. Meanwhile, Russia has claimed that its Sputnik V coronavirus vaccine is 92 per cent effective. And, India's 'Covaxin', Oxford-Astrazeneca, and Johnson & Johnson's vaccine have all shown promising results at different stages of trials.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.
OR

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

Read our full coverage on Coronavirus Vaccine

First Published: Tue, November 17 2020. 16:27 IST

`
RECOMMENDED FOR YOU